A protest over a draft decision not to recommend a new cystic fibrosis drug is due later. Campaigners keen to see Kalydeco introduced across Wales are aiming to make their voices heard outside a meeting of the All Wales Medicines Strategy Group at the Angel Hotel in Abergavenny.
The group will look at the recommendation and decide whether to approve it or not. The drug - which is already available in England, Scotland and Northern Ireland - is the first licensed drug that treats the G551D mutation - the fundamental defect in those with cystic fibrosis.
More top news
This week Carl talks to psychologist Amy McClelland about new research on the sleeping habits of babies.
For those who have mobility problems the idea of a walk in the Welsh mountains may seem unlikely. But this new scheme may change that.
Any rain will eventually clear this afternoon, bringing brighter weather behind it.